RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/16007096http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/16007096http://www.w3.org/2000/01/rdf-schema#comment"Suppressor of cytokine signaling (SOCS) 3 attenuates proinflammatory signaling mediated by the signal transducer and activator of transcription (STAT) family of proteins. But acute inflammation can occur after exposure to pathogen-derived inducers staphylococcal enterotoxin B (SEB) and lipopolysaccharide (LPS), or the lectin concanavalin A (ConA), suggesting that physiologic levels of SOCS3 are insufficient to stem proinflammatory signaling under pathogenic circumstances. To test this hypothesis, we developed recombinant cell-penetrating forms of SOCS3 (CP-SOCS3) for intracellular delivery to counteract SEB-, LPS- and ConA-induced inflammation. We found that CP-SOCS3 was distributed in multiple organs within 2 h and persisted for at least 8 h in leukocytes and lymphocytes. CP-SOCS3 protected animals from lethal effects of SEB and LPS by reducing production of inflammatory cytokines and attenuating liver apoptosis and hemorrhagic necrosis. It also reduced ConA-induced liver apoptosis. Thus, replenishing the intracellular stores of SOCS3 with CP-SOCS3 effectively suppresses the devastating effects of acute inflammation."xsd:string
http://purl.uniprot.org/citations/16007096http://purl.org/dc/terms/identifier"doi:10.1038/nm1269"xsd:string
http://purl.uniprot.org/citations/16007096http://purl.uniprot.org/core/author"Liu D."xsd:string
http://purl.uniprot.org/citations/16007096http://purl.uniprot.org/core/author"Yao S."xsd:string
http://purl.uniprot.org/citations/16007096http://purl.uniprot.org/core/author"Jo D."xsd:string
http://purl.uniprot.org/citations/16007096http://purl.uniprot.org/core/author"Hawiger J."xsd:string
http://purl.uniprot.org/citations/16007096http://purl.uniprot.org/core/author"Collins R.D."xsd:string
http://purl.uniprot.org/citations/16007096http://purl.uniprot.org/core/date"2005"xsd:gYear
http://purl.uniprot.org/citations/16007096http://purl.uniprot.org/core/name"Nat Med"xsd:string
http://purl.uniprot.org/citations/16007096http://purl.uniprot.org/core/pages"892-898"xsd:string
http://purl.uniprot.org/citations/16007096http://purl.uniprot.org/core/title"Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis."xsd:string
http://purl.uniprot.org/citations/16007096http://purl.uniprot.org/core/volume"11"xsd:string
http://purl.uniprot.org/citations/16007096http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/16007096
http://purl.uniprot.org/citations/16007096http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/16007096
http://purl.uniprot.org/uniprot/#_O35718-mappedCitation-16007096http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/16007096
http://purl.uniprot.org/uniprot/#_Q3U9J8-mappedCitation-16007096http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/16007096
http://purl.uniprot.org/uniprot/Q3U9J8http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/16007096
http://purl.uniprot.org/uniprot/O35718http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/16007096